Track topics on Twitter Track topics that are important to you
The Cooper Companies (NYSE:COO) announced financial results for the fiscal fourth quarter and full year ended October 31, 2018. As quoted in the press release: Revenue $651.5 million up 16% from last year’s fourth quarter, up 9% pro forma (defined as constant currency, including acquisitions and excluding carrier screening and NIPT in both periods). Gross … Continued
The post The Cooper Companies Announces Fourth Quarter and Full Year 2018 Results appeared first on Investing News Network.
Original Article: The Cooper Companies Announces Fourth Quarter and Full Year 2018 ResultsNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.